Injective (INJ) has stabilized near the $3 price level, a zone analysts identify as a historically critical long-term support. The token’s Relative Strength Index (RSI) has rebounded from oversold territory, indicating easing bearish pressure. Crypto analyst Crypto Pulse suggests that if the support holds, a potential relief rally toward $8–$10 could materialize in the short term.
The Injective (INJ) token has returned to a crucial long-term support level near $3 following a market sell-off. According to crypto analyst Crypto Pulse, this price zone has repeatedly acted as strong historical support for traders.
Holding this $3 level is viewed as critical for short-term stability. A successful defense could catalyze a relief rally toward the $8–$10 range, according to the analysis.
Technical indicators show early signs of decreasing selling pressure. The token’s RSI has risen to 37.70 after recently touching oversold levels near 32.83.
The MACD indicator also suggests bearish momentum is weakening. Its histogram shows the MACD line rising toward the signal line, a potential precursor to a bullish crossover.
Despite price volatility, the Injective Protocol continues to see increased net flows. This trend indicates sustained investor confidence and participation in its markets.
Analysts link these consistent capital inflows to the protocol’s underlying strength and adoption. Injective’s focus on layer 2 derivatives and cross-chain capabilities attracts both retail and institutional interest.
